Inhibition of hepatitis C virus gene expression by adenoviral vectors encoding antisense RNA in vitro and in vivo

Journal of Hepatology

Volumn 55, Issue 1, 2011, Pages 19-28

  González Carmona, Maria A ^a   Vogt, Annabelle ^a   Heinicke, Thomas ^a   Quasdorff, Maria ^b   Hoffmann, Per ^a   Yildiz, Yildiz ^a   Schneider, Carlo ^a,e   Serwe, Matthias ^a,f   Bartenschlager, Ralf ^d   Sauerbruch, Tilman ^a   Caselmann, Wolfgang H ^a,c  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

^c Bavarian State Ministry of the Environment   (Germany)

^d UNIVERSITY OF HEIDELBERG   (Germany)

^e UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^f Deutsche Krebshilfe e V   (Germany)

Author keywords

5 Noncoding region; Adenoviral vector; Antisense RNA; Hepatitis C virus

Indexed keywords

ADENOVIRUS VECTOR; COMPLEMENTARY RNA; UNTRANSLATED RNA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL STRAIN HEPG2; CONTROLLED STUDY; GENE EXPRESSION; HEPATITIS C VIRUS; HEPATOMA CELL; IN VITRO STUDY; IN VIVO STUDY; LIVER; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPLICON; VIRUS REPLICATION;

5' UNTRANSLATED REGIONS; ADENOVIRIDAE; ANIMALS; CELL LINE; GENE EXPRESSION; GENES, VIRAL; GENETIC VECTORS; HEPACIVIRUS; HEPATITIS C, CHRONIC; INJECTIONS, INTRAVENOUS; MALE; MICE; MICE, INBRED C3H; REPLICON; RNA, ANTISENSE; TRANSDUCTION, GENETIC; VIRUS REPLICATION;

EID: 79958773820     PISSN: 01688278     EISSN: 01688278     Source Type: Journal    
DOI: 10.1016/j.jhep.2010.11.010     Document Type: Article

References (32)

1. J.G. McHutchison, M. Manns, K. Patel, T. Poynard, K.L. Lindsay, and C. Trepo Adherence to combination therapy enhances sustained response in genotype-1-infected patients with chronic hepatitis C Gastroenterology 123 2002 1061 1069
2. V. Soriano, M.G. Peters, and S. Zeuzem New therapies for hepatitis C virus infection Clin Infect Dis 48 2009 313 320
3. J. Bukh, R.H. Purcell, and R.H. Miller Sequence analysis of the 5′ noncoding region of hepatitis C virus Proc Natl Acad Sci USA 89 1992 4942 4946
4. C. Wang, P. Sarnow, and A. Siddiqui Translation of human hepatitis C virus RNA in cultured cells is mediated by an internal ribosome-binding mechanism J Virol 67 1993 3338 3344 (Pubitemid 23143708)
5. A. Sen, R. Steele, A.K. Ghosh, A. Basu, R. Ray, and R.B. Ray Inhibition of hepatitis C virus protein expression by RNA interference Virus Res 96 2003 27 35 (Pubitemid 37297678)
6. M. Alt, R. Renz, P.H. Hofschneider, G. Paumgartner, and W.H. Caselmann Specific inhibition of hepatitis C viral gene expression by antisense phosphorothioate oligodeoxynucleotides Hepatology 22 1995 707 717
7. T. Wakita, D. Moradpour, K. Tokushihge, and J.R. Wands Antiviral effects of antisense RNA on hepatitis C virus RNA translation and expression J Med Virol 57 1999 217 222 (Pubitemid 29069726)
8. M.A. Gonzalez-Carmona, S. Schussler, M. Serwe, M. Alt, and J. Ludwig Hammerhead ribozymes with cleavage site specificity for NUH and NCH display significant anti-hepatitis C viral effect in vitro and in recombinant HepG2 and CCL13 cells J Hepatol 44 2006 1017 1025
9. E. Urban, and C.R. Noe Structural modifications of antisense oligonucleotides Farmaco 58 2003 243 258 (Pubitemid 36279698)
10. C. Volpers, and S. Kochanek Adenoviral vectors for gene transfer and therapy J Gene Med 6 2004 S164 S171
11. K. Jooss, and N. Chirmule Immunity to adenovirus and adeno associated viral vectors: implications for gene therapy Gene Ther 10 2003 955 963 (Pubitemid 36722430)
12. F.J. Fallaux, O. Kranenburg, S.J. Cramer, A. Houweling, H. Van Ormondt, and R.C. Hoeben Characterization of 911: a new helper cell line for the titration and propagation of early region 1-deleted adenoviral vectors Hum Gene Ther 7 1996 215 222 (Pubitemid 26044840)
13. T.C. He, S. Zhou, L.T. da Costa, J. Yu, K.W. Kinzler, and B. Vogelstein A simplified system for generating recombinant adenoviruses Proc Natl Acad Sci USA 95 1998 2509 2514 (Pubitemid 28145972)
14. J.M. Bergelson, J.A. Cunningham, G. Droguett, E.A. Kurt-Jones, A. Krithivas, and J.S. Hong Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5 Science 275 1997 1320 1323 (Pubitemid 27114163)
15. V. Lohmann, F. Korner, J. Koch, U. Herian, L. Theilmann, and R. Bartenschlager Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line Science 285 1999 110 113 (Pubitemid 29307577)
16. J. Krönke, R. Kittler, F. Buchholz, M.P. Windisch, T. Pietschmann, and R. Bartenschlager Alternative approaches for efficient inhibition of hepatitis C virus RNA replication by small interfering RNAs J Virol. 78 2004 3436 3446 (Pubitemid 38568285)
17. T. Wakita, T. Pietschmann, T. Kato, T. Date, M. Miyamoto, and Z. Zhao Production of infectious hepatitis C virus in tissue culture from a cloned viral genome Nat Med. 11 2005 791 796 (Pubitemid 41021213)
18. V. Guerniou, R. Gillet, F. Berree, B. Carboni, and B. Felden Targeted inhibition of the hepatitis C internal ribosomal entry site genomic RNA with oligonucleotide conjugates Nucleic Acids Res 35 2007 67786787
19. L. Neckers, and L. Whitesell Antisense technology: biological utility and practical considerations Am J Physiol 265 1993 L1 L12
20. B. Weiss, G. Davidkova, and L.W. Zhou Antisense RNA gene therapy for studying and modulating biological processes Cell Mol Life Sci. 55 1999 334 358 (Pubitemid 29178878)
21. T.A. Vickers, J.R. Wyatt, and S.M. Freier Effects of RNA secondary structure on cellular antisense activity Nucleic Acids Res 28 2000 1340 1347 (Pubitemid 30142676)
22. X. Ji The mechanism of RNase III action: how dicer dices Curr Top Microbiol Immunol 320 2008 99 116
23. P.L. Iversen, S. Zhu, A. Meyer, and G. Zon Cellular uptake and subcellular distribution of phosphorothioate oligonucleotides into cultured cells Antisense Res Dev 2 1992 211 222
24. W.W. Zhang Development and application of adenoviral vectors for gene therapy of cancer Cancer Gene Ther 6 1999 113 138
25. M. Nakano, K. Aoki, N. Matsumoto, S. Ohnami, K. Hatanaka, and T. Hibi Suppression of colorectal cancer growth using an adenovirus vector expressing an antisense K-ras RNA Mol Ther 3 2001 491 499 (Pubitemid 32509842)
26. C.L. Jopling Regulation of hepatitis C virus by microRNA-122 Biochem Soc Trans 36 2008 1220 1223
27. R.E. Lanford, E.S. Hildebrandt-Eriksen, A. Petri, R. Persson, M. Lindow, and M.E. Munk Science 327 2010 198 201
28. S. Bai, M.W. Nasser, B. Wang, S. Hsu, J. Datta, and H. Kutay MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenib J Biol Chem 284 2009 32015 32027
29. H. Okamoto, and S. Mishiro Genetic heterogeneity of hepatitis C virus Intervirology 37 1994 68 76 (Pubitemid 24289503)
30. C.E. Thomas, A. Ehrhardt, and M.A. Kay Progress and problems with the use of viral vectors for gene therapy Nat Rev Genet 4 2003 346 358 (Pubitemid 36538359)
31. J.F. Dedieu, E. Vigne, C. Torrent, C. Jullien, I. Mahfouz, and J.M. Caillaud Long-term gene delivery into the livers of immunocompetent mice with E1/E4-defective adenoviruses J Virol 71 1997 4626 4637 (Pubitemid 27204155)
32. L. Grave, D. Dreyer, A. Dieterle, P. Leroy, A.I. Michou, and C. Doderer Differential influence of the E4 adenoviral genes on viral and cellular promoters J Gene Med 2 2000 433 443